1. Circulating uncarboxylated matrix Gla protein in patients with atrial fibrillation or heart failure with preserved ejection fraction.
- Author
-
Nazifova-Tasinova, Neshe Ferahova, Atanasov, Atanas Angelov, Pasheva, Milena Gincheva, Yotov, Yoto Trifonov, Gerova, Daniela Ivanova, Vankova, Deyana Georgieva, Todorova, Miglena Nikolaeva, Ivanova, Diana Georgieva, Kiselova-Kaneva, Yoana Dimitrova, and Galunska, Bistra Tzaneva
- Subjects
- *
ATRIAL fibrillation , *MATRIX Gla protein , *HEART failure , *VENTRICULAR ejection fraction , *CORONARY artery calcification , *FRACTIONS - Abstract
Circulating uncarboxylated matrix Gla protein (ucMGP) is possibly related to coronary arterial calcification (CAC) in cardiovascular disease (CVD) patients. We aimed to evaluate the relationships between circulating ucMGP, CVD pathology and CAC and its interplay with CVD risk factors. ucMGP was measured in 99 CVD-patients. CAC score was determined by multislice computed tomography. Circulating ucMGP, uncarboxylated (ucOC) and carboxylated osteocalcin (cOC) were assayed by ELISA kits. Vitamin-K status was evaluated by ucOC/cOC ratio. A tendency for decreased ucMGP was observed for CAC ≥ 100 AU vs. CAC = 1-99 AU after exclusion of the patients on vitamin K-antagonist anticoagulants. Significant inverse correlations between ucMGP and vitamin-K status were indicated for the entire cohort and according to CAC score. Significant associations were found between ucMGP and risk factors for CVD. Circulating ucMGP may reflect certain stages of CVD and CAC. Future studies are needed to clarify its role as potential biomarker. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF